Theravance Biopharma (TBPH) Capital Expenditures Growth (1y) (2014 - 2025)
Theravance Biopharma (TBPH) Capital Expenditures Growth (1y) (2014 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Capex Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
719,706.53 Bn |
719,706.50 Bn |
- |
- |
| 2 |
Belite Bio |
55,800.00 Bn |
55,800.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
18,182.30 Bn |
18,182.29 Bn |
- |
- |
| 4 |
Legend Biotech |
3,154.00 Bn |
3,153.71 Bn |
242.10 Mn |
- |
| 5 |
Akari Therapeutics |
1,844.30 Bn |
1,844.29 Bn |
- |
- |
| 6 |
Evaxion A |
1,567.96 Bn |
1,567.94 Bn |
- |
- |
| 7 |
Psyence Biomedical |
251.43 Bn |
251.42 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
112.56 Bn |
105.31 Bn |
2.59 Bn |
227.76% |
| 9 |
Abivax |
94.37 Bn |
94.37 Bn |
- |
- |
| 10 |
Theravance Biopharma |
835.85 Mn |
441.18 Mn |
- |
- |
| Date | Value |
|---|
| Dec 31, 2025 |
-95.79% |
| Dec 31, 2024 |
-71.94% |
| Sep 30, 2024 |
-28.57% |
| Jun 30, 2024 |
-95.77% |
| Mar 31, 2024 |
-90.30% |
| Dec 31, 2023 |
154.51% |
| Sep 30, 2023 |
136.84% |
| Jun 30, 2023 |
653.98% |
| Mar 31, 2023 |
275.20% |
| Dec 31, 2022 |
-40.09% |
| Sep 30, 2022 |
-105.49% |
| Jun 30, 2022 |
-27.56% |
| Mar 31, 2022 |
-85.85% |
| Dec 31, 2021 |
-64.31% |
| Sep 30, 2021 |
-49.32% |
| Jun 30, 2021 |
-93.41% |
| Mar 31, 2021 |
85.22% |
| Dec 31, 2020 |
-4.53% |
| Sep 30, 2020 |
2,562.34% |
| Jun 30, 2020 |
311.11% |
